STUDY OF BACTERIAL LYSATE IN THE FIGHT AGAINST ANTIBIOTIC RESISTANCE
Main Article Content
Authors
D.A. Junussova
LLP “Scientific and Analytical Center “Biomedpreparat”, Monitoring Laboratory, Stepnogorsk, Kazakhstan, 9th microdistrict, building 3, 021500
A.M. Sadykov
LLP “Scientific and Analytical Center “Biomedpreparat”, Monitoring Laboratory, Stepnogorsk, Kazakhstan, 9th microdistrict, building 3, 021500
M.A. Kanafina
LLP “Scientific and Analytical Center “Biomedpreparat”, Monitoring Laboratory, Stepnogorsk, Kazakhstan, 9th microdistrict, building 3, 021500
D.E. Sharova
LLP “Scientific and Analytical Center “Biomedpreparat”, Monitoring Laboratory, Stepnogorsk, Kazakhstan, 9th microdistrict, building 3, 021500
D. Issa
JSC “Scientific Center for Anti-Infectious Drugs”, Laboratory of pharmacology and toxicology, Scientific Center for Anti-Infectious Drugs, Almaty, Kazakhstan, Al-Farabi Avenue 73B, 050000
Abstract
Bacterial lysates are widely used today as immunomodulatory agents that enhance the effectiveness of antibacterial therapy through synergistic interactions with antibiotics. The aim of this study was to evaluate the pharmacological properties of a bacterial lysate obtained from antibiotic-resistant strains of opportunistic microorganisms such as Acinetobacter baumaniі, Klebsiella pneumoniae SCAID PND1-2022 (246), and Pseudomonas aeruginosa SCAID PHRX1-2019 to assess its potential in combating the growing problem of antimicrobial resistance. The study analyzed the properties of the lysate and its effects on the body using in vivo studies at doses of 300.0 and 500.0 mg/kg. No signs of acute toxicity were observed, suggesting that this substance is safe for use. Furthermore, destroyed bacterial cells retain the ability to induce a specific immune response, stimulating immune system activation. Given the inherent resistance of bacterial strains to antibiotics, it can be concluded that the use of bacterial lysate promotes the development of an adaptive immune response directed against highly resistant pathogens, including superbugs.
Keywords
antibiotic resistance, lysate, preclinical trials, immunomodulator, opportunistic, acute toxicity
Article Details
References
Janeczek K., Emeryk A., Rachel M., Duma D., Zimmer Ł., Poleszak E. Polyvalent Mechanical Bacterial Lysate Administration Improves the Clinical Course of Grass Pollen – Induced Allergic Rhinitis in Children: A Randomized Controlled Trial // The Journal of Allergy and Clinical Immunology: In Practice. – 2020. – Vol. 9, № 1, P. 453 – 462. doi: 10.1016/j.jaip.2020.08.025.
Rajasekhar B., Sumalatha M., Baji S., Lokesh P.V., Rani G.V. A Review on Immunological Effects of Bacterial Lysate in Upper Respiratory tract Infection // Journal of Pharmaceutical Research and Applications. – 2025. – Vol. 10. – P. 1252-1257. doi: 10.35629/4494-100112521257.
Braido F., Melioli G., Nicolini G., Ferraris M., Girolamo S., Gioacchino M., Canonica G.W. Sublingually administered bacterial lysates: rationale, mechanisms of action and clinical outcomes // Drugs Context. – 2024. – Vol. 13. – P. 1-5. doi:10.7573/dic.2024-1-5.
Kostinov M., Chuchalin A., Svitich O., Gaynitdinova V., Mashilov K., Kryukova N., Osiptsov V., Tatevosov V., Khromova E., Baranova I., Vlasenko A., Shogenova L., Mekhantseva I., Khrapunova I., Linok A., Kostinov A., Polishchuk V., Poddubikov A.. Bacterial lysates in modifying sIgA levels in the upper respiratory tract in COVID-19 patients// Scientific Reports. – 2025. – Vol. 15, No. 8325. – doi: 10.1038/s41598-025-92794-z.
Bacterial lysate medicines for respiratory conditions to be used only for prevention of recurrent infections// European Medicines Agency's. – 2019. URL (date of access: 28.04.2025).
Piano Nazionale di Contrasto all’Antibiotico-Resistenza (PNCAR) 2022-2025 // World Health Organization AMR national action plans. – 2023. URL (date of access: 28.04.2025).
Lanzilli G., Falchetti R., Cottarelli A., Macchi A., Ungheri D., Fuggetta M.P. In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes // International Journal of Immunopathology and Pharmacology. – 2006. – Vol. 19(3). – P. 551-559. doi:10.1177/039463200601900311